Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

INTERPHEX2011 Confirms FDA Participation in Conference

By Pharmaceutical Processing | February 22, 2011

INTERPHEX recently announced that they have confirmed two
FDA panelists for their educational conference.

Francis Godwin, FDA Compliance Officer will be presenting
the FDA’s views on continuous manufacturing during his session: Continuous
Manufacturing, a Regulatory Perspective on Tuesday, March 29th at 10 am.

As the pharmaceutical and biotechnology industries
increase utilization of continuous manufacturing, questions have arisen
regarding the regulatory implications of implementing these technologies. FDA
supports continuous manufacturing, and to facilitate use of new technologies
and continuous improvement, Godwin will discuss the following topics in regards
to continuous manufacturing: (1) Advantages/Disadvantages, (2) Importance of
upfront design, (3) Role of process control, (4) Sampling considerations, (5)
Related PAT principles, (6) CGMP regulations, and (7) Process validation.

Also on Tuesday, Dr. Steven Wolfgang, who leads a Data
Analysis Team at the FDA Center for Drug Evaluation and Research, in the Office
of Compliance’s Division of Manufacturing and Product Quality, will participate
in a panel discussion title: Leveraging Technology to Ensure Raw Material
Supply Chain Security in the Pharmaceutical Industry

This educational session will provide an overview of one
of the largest threats facing the pharmaceutical industry today, the risk of
adulterated materials, and what industry is doing to address this risk and
protect patients. The session will provide the latest understandings and
expectations from FDA on this subject. The session features a specific case
study from both an equipment provider’s perspective and a user’s perspective
where high tech analytical equipment, Nuclear Magnetic Resonance (NMR), was
introduced to QC operations. NMR is a powerful detection tool being employed to
detect potential adulterated materials and prevent their use in production.

In addition, the session will provide an overview of
Rx-360, a non-profit consortium involving pharmaceutical and raw material
supplier companies. This consortium has been established to share market
surveillance, develop operating standards, create an independent supplier audit
function to improve the efficiency, oversight and accountability of the
pharmaceutical supply chain, and advance technologies for detection and
prevention of material adulteration. Other panel speakers include: Vinny
Browning – Sr. Manager QC, Amgen; Kimberly L. Colson, Ph.D. – Business
Development Manager, R&D Division,, Bruker BioSpin; and Jared Byrne, Amgen

 

Related Articles Read More >

downtown
INTERPHEX Wrap-Up
INTERPHEX Minute: Day 3
gold particles
2019 Interphex Exhibitor Award Winners Announced
INTERPHEX Minute: Day 2

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards